US Stock MarketDetailed Quotes
COGT Cogent Biosciences
- 9.235
- +0.155+1.71%
Trading Nov 21 13:02 ET
1.02BMarket Cap-3723P/E (TTM)
9.270High9.010Low276.03KVolume9.120Open9.080Pre Close2.53MTurnover0.43%Turnover RatioLossP/E (Static)110.46MShares12.61052wk High5.00P/B592.94MFloat Cap3.67052wk Low--Dividend TTM64.21MShs Float174.200Historical High--Div YieldTTM2.86%Amplitude1.904Historical Low9.159Avg Price1Lot Size
About Cogent Biosciences Company
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
Company Profile
SymbolCOGT
Company NameCogent Biosciences
Listing DateMar 29, 2018
Issue Price12.00
Founded2014
CEOMr. Andrews R. Robbins, M.B.A.
MarketNASDAQ
Employees164
Fiscal Year Ends12-31
Address275 Wyman Street,3rd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-945-5576
Websitehttp://www.cogentbio.com
Company Executives
- Name
- Position
- Salary
- Andrews R. Robbins, M.B.A.
- Director, Chief Executive Officer and President
- 7.90M
- John Green
- Chief Financial Officer and Principal Accounting Officer
- --
- Evan Kearns
- Chief Legal Officer and Corporate Secretary
- --
- Dr. Jessica Sachs, PhD
- Chief Medical Officer
- 3.00M
- Dr. John Edward Robinson, PhD
- Chief Scientific Officer
- 2.98M
- Peter Harwin
- Chairman of the Board
- 364.55K
- Dr. Karen Jean Ferrante, M.D.
- Independent Director
- 340.37K
- Dr. Chris Cain, PhD
- Independent Director
- 341.36K
- Todd E. Shegog
- Independent Director
- 345.80K
- Matthew E. Ros
- Independent Director
- 336.69K
- Arlene M. Morris
- Independent Director
- 345.49K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data